CN101684121A - 培美曲塞二酸的新晶型及其制备方法 - Google Patents
培美曲塞二酸的新晶型及其制备方法 Download PDFInfo
- Publication number
- CN101684121A CN101684121A CN200810070345A CN200810070345A CN101684121A CN 101684121 A CN101684121 A CN 101684121A CN 200810070345 A CN200810070345 A CN 200810070345A CN 200810070345 A CN200810070345 A CN 200810070345A CN 101684121 A CN101684121 A CN 101684121A
- Authority
- CN
- China
- Prior art keywords
- pemetrexed
- pemetrexed diacid
- water
- crystal formation
- diacid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (12)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100703459A CN101684121B (zh) | 2008-09-22 | 2008-09-22 | 培美曲塞二酸的新晶型及其制备方法 |
CA2737967A CA2737967C (en) | 2008-09-22 | 2009-09-21 | New crystalline forms of pemetrexed diacid, and preparations thereof |
US13/120,080 US8324382B2 (en) | 2008-09-22 | 2009-09-21 | Crystalline forms of Pemetrexed diacid, and preparations thereof |
PCT/CN2009/074059 WO2010031357A1 (zh) | 2008-09-22 | 2009-09-21 | 培美曲塞二酸的新晶型及其制备方法 |
JP2011527193A JP5536070B2 (ja) | 2008-09-22 | 2009-09-21 | ペメトレキセド二酸の新規結晶型及びその製造方法 |
EP09814077.5A EP2351755B1 (en) | 2008-09-22 | 2009-09-21 | New crystalline forms of pemetrexed diacid, and preparations thereof |
AU2009295094A AU2009295094B2 (en) | 2008-09-22 | 2009-09-21 | New crystalline forms of pemetrexed diacid, and preparations thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100703459A CN101684121B (zh) | 2008-09-22 | 2008-09-22 | 培美曲塞二酸的新晶型及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101684121A true CN101684121A (zh) | 2010-03-31 |
CN101684121B CN101684121B (zh) | 2013-04-03 |
Family
ID=42039100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100703459A Active CN101684121B (zh) | 2008-09-22 | 2008-09-22 | 培美曲塞二酸的新晶型及其制备方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US8324382B2 (zh) |
EP (1) | EP2351755B1 (zh) |
JP (1) | JP5536070B2 (zh) |
CN (1) | CN101684121B (zh) |
AU (1) | AU2009295094B2 (zh) |
CA (1) | CA2737967C (zh) |
WO (1) | WO2010031357A1 (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103040834A (zh) * | 2012-12-25 | 2013-04-17 | 山西普德药业股份有限公司 | 一种注射用培美曲塞二钠及其制备方法 |
CN104098573A (zh) * | 2013-04-10 | 2014-10-15 | 重庆医药工业研究院有限责任公司 | 培美曲塞盐及其制备方法 |
CN104119345A (zh) * | 2014-06-18 | 2014-10-29 | 威海昊同医药科技有限公司 | 一种注射级培美曲塞二钠的纯化方法 |
TWI551603B (zh) * | 2014-10-30 | 2016-10-01 | 台灣神隆股份有限公司 | 培美曲塞二酸之晶型及其製備方法 |
CN107641124A (zh) * | 2016-07-22 | 2018-01-30 | 上海创诺制药有限公司 | 一种培美曲塞二酸新晶型及其制备方法 |
CN114262332A (zh) * | 2020-09-16 | 2022-04-01 | 齐鲁制药有限公司 | 培美曲塞二酸新晶型及其制备方法 |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6754487B1 (en) | 2000-02-28 | 2004-06-22 | Telecom Network Optimization, Inc. | Radio network test analysis system |
JP2008543975A (ja) | 2006-08-14 | 2008-12-04 | シコール インコーポレイティド | 高度に純粋なペメトレキセド二酸およびその調製方法 |
US8088919B2 (en) | 2006-08-14 | 2012-01-03 | Sicor Inc. | Crystalline forms of pemetrexed diacid and processes for the preparation thereof |
JP5826371B2 (ja) * | 2011-03-25 | 2015-12-02 | サイノファーム タイワン リミテッド | ペメトレキセド塩の製造方法 |
NZ705994A (en) * | 2012-10-17 | 2015-08-28 | Shilpa Medicare Ltd | Process for preparing pemetrexed di potassium and its hydrates |
WO2014060962A1 (en) * | 2012-10-17 | 2014-04-24 | Shilpa Medicare Limited | Pemetrexed dipotassium formulations |
WO2014060959A1 (en) * | 2012-10-17 | 2014-04-24 | Shilpa Medicare Limited | Crystalline pemetrexed dipotassium process |
EP2997031A1 (en) | 2013-05-17 | 2016-03-23 | Instytut Farmaceutyczny | Process for the preparation of high purity amorphous pemetrexed disodium and crystalline forms of n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3- d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid |
WO2015008221A1 (en) | 2013-07-16 | 2015-01-22 | Dr. Reddy’S Laboratories Limited | Novel crystalline forms of pemetrexed tromethamine salts |
NZ630292A (en) * | 2013-11-25 | 2015-02-27 | Shilpa Medicare Ltd | Process for crystalline pemetrexed dipotassium salt |
NZ630299A (en) | 2014-06-30 | 2014-11-28 | Shilpa Medicare Ltd | Pemetrexed dipotassium formulations |
WO2017168442A1 (en) * | 2016-03-26 | 2017-10-05 | Dharmesh Mahendrabhai Shah | Novel stable salts of pemetrexed |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO169490C (no) * | 1988-03-24 | 1992-07-01 | Takeda Chemical Industries Ltd | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater |
IL96531A (en) * | 1989-12-11 | 1995-08-31 | Univ Princeton | History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them) |
KR0162654B1 (ko) * | 1989-12-11 | 1998-11-16 | 알렌 제이. 시니스갤리 | N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체 |
US5416211A (en) * | 1992-09-25 | 1995-05-16 | Eli Lilly And Company | Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines |
IL135190A (en) * | 1997-09-26 | 2005-03-20 | Lilly Co Eli | Processes and intermediates useful to make antifolates |
US6262262B1 (en) * | 1997-09-26 | 2001-07-17 | Eli Lilly And Company | Processes and intermediates useful to make antifolates |
WO2001014379A2 (en) | 1999-08-23 | 2001-03-01 | Eli Lilly And Company | A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor |
PT1259513E (pt) * | 2000-02-25 | 2004-02-27 | Lilly Co Eli | Nova forma cristalina de acido n-¬4- ¬2-amino-4,7-dihidro -4-oxo-3h-pirrolo¬2,3-d|pirimidin-5-il)etil| - benzoil|-l-glutamico e processo para a sua obtencao |
IL159861A0 (en) * | 2001-08-03 | 2004-06-20 | Ciba Sc Holding Ag | Crystalline forms of fluvastatin sodium |
CN100344615C (zh) * | 2004-11-25 | 2007-10-24 | 重庆医药工业研究院有限责任公司 | 制备N-(吡咯并[2,3-d]嘧啶-5-基)酰基谷氨酸衍生物的方法及中间体 |
CN1840530B (zh) * | 2005-03-28 | 2010-06-02 | 齐鲁制药有限公司 | 培美曲塞的制备方法 |
CN100379729C (zh) * | 2006-04-06 | 2008-04-09 | 海南天源康泽医药科技有限公司 | 硝基化合物及其在培美曲塞制备中的应用 |
US7994180B2 (en) * | 2006-08-14 | 2011-08-09 | Sicor Inc. | Processes for preparing intermediates of pemetrexed |
KR101083230B1 (ko) * | 2006-08-14 | 2011-11-11 | 시코르, 인크. | 페메트렉세드 이산의 동결 건조된 약학적 허용염의 제조 방법 |
JP2008543975A (ja) * | 2006-08-14 | 2008-12-04 | シコール インコーポレイティド | 高度に純粋なペメトレキセド二酸およびその調製方法 |
US8088919B2 (en) * | 2006-08-14 | 2012-01-03 | Sicor Inc. | Crystalline forms of pemetrexed diacid and processes for the preparation thereof |
JP2008059088A (ja) * | 2006-08-29 | 2008-03-13 | Toshiba Corp | 画像表示システム、及び画像表示装置 |
EP2129674A2 (en) | 2007-04-03 | 2009-12-09 | Dr. Reddy's Laboratories Ltd. | Solid forms of pemetrexed |
EP2334685A4 (en) | 2008-09-08 | 2011-10-26 | Reddys Lab Ltd Dr | AMORPHOUS PEMETREXED DISODIUM |
-
2008
- 2008-09-22 CN CN2008100703459A patent/CN101684121B/zh active Active
-
2009
- 2009-09-21 US US13/120,080 patent/US8324382B2/en active Active
- 2009-09-21 EP EP09814077.5A patent/EP2351755B1/en active Active
- 2009-09-21 CA CA2737967A patent/CA2737967C/en not_active Expired - Fee Related
- 2009-09-21 WO PCT/CN2009/074059 patent/WO2010031357A1/zh active Application Filing
- 2009-09-21 AU AU2009295094A patent/AU2009295094B2/en not_active Ceased
- 2009-09-21 JP JP2011527193A patent/JP5536070B2/ja not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103040834A (zh) * | 2012-12-25 | 2013-04-17 | 山西普德药业股份有限公司 | 一种注射用培美曲塞二钠及其制备方法 |
CN104098573A (zh) * | 2013-04-10 | 2014-10-15 | 重庆医药工业研究院有限责任公司 | 培美曲塞盐及其制备方法 |
CN104119345A (zh) * | 2014-06-18 | 2014-10-29 | 威海昊同医药科技有限公司 | 一种注射级培美曲塞二钠的纯化方法 |
TWI551603B (zh) * | 2014-10-30 | 2016-10-01 | 台灣神隆股份有限公司 | 培美曲塞二酸之晶型及其製備方法 |
CN107641124A (zh) * | 2016-07-22 | 2018-01-30 | 上海创诺制药有限公司 | 一种培美曲塞二酸新晶型及其制备方法 |
CN114262332A (zh) * | 2020-09-16 | 2022-04-01 | 齐鲁制药有限公司 | 培美曲塞二酸新晶型及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
EP2351755B1 (en) | 2014-11-12 |
CA2737967C (en) | 2017-04-04 |
US20110172424A1 (en) | 2011-07-14 |
JP2012502933A (ja) | 2012-02-02 |
WO2010031357A1 (zh) | 2010-03-25 |
EP2351755A4 (en) | 2012-06-13 |
US8324382B2 (en) | 2012-12-04 |
JP5536070B2 (ja) | 2014-07-02 |
CA2737967A1 (en) | 2010-03-25 |
EP2351755A1 (en) | 2011-08-03 |
CN101684121B (zh) | 2013-04-03 |
AU2009295094A1 (en) | 2010-03-25 |
AU2009295094B2 (en) | 2012-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101684121B (zh) | 培美曲塞二酸的新晶型及其制备方法 | |
KR101045616B1 (ko) | 페메트렉세드 이산의 결정형 및 이의 제조 방법 | |
US9718829B2 (en) | Crystalline forms of pemetrexed diacid and processes for the preparation thereof | |
CN110092745B (zh) | 一种含芳环的化合物及其应用 | |
CN112979679B (zh) | 具有大环结构的含氟并杂环衍生物及其用途 | |
CN109400540A (zh) | 一种烟酰胺甲基吡嗪衍生物共晶a | |
CN115160321B (zh) | 一种伐地那非类似物及其合成方法和应用 | |
CN110407877A (zh) | 新颖螺环芳基磷氧化物的多晶型 | |
CN101421284A (zh) | 伊班膦酸的结晶形式和其制备方法 | |
CN102321083B (zh) | 一种无水盐酸莫西沙星晶型f的制备方法 | |
CN110092799B (zh) | 一种环状化合物、其制备方法和应用 | |
CN106995452A (zh) | 一种噻吩并[3,2‑d]嘧啶类EGFR/ErbB2双靶点抑制剂及其制备方法和用途 | |
US9505792B2 (en) | Forms of cidofovir | |
CN104470526B (zh) | 埃克替尼磷酸盐的晶型及其用途 | |
CN113461694A (zh) | 一种伐地那非类似物及其合成方法和应用 | |
CN114436973A (zh) | 一种氟尿嘧啶新晶型及其制备方法和应用 | |
CN106187886A (zh) | 一种制备高纯度伯舒替尼一水合物的方法 | |
CN104693200A (zh) | 一种盐酸莫西沙星的晶型及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181227 Address after: 401221 No. 2 Yanjiahua South Third Branch Road, Changshou District, Chongqing Co-patentee after: Chongqing Pharmaceutical Research Institute Co., Ltd. Patentee after: Chongqing Medical Institute Pharmaceutical Co., Ltd. Address before: 400061 Tu Shan Road, South Bank district, Chongqing, No. 565 Patentee before: Chongqing Pharmaceutical Research Institute Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200415 Address after: 401221, No. 3, No. 1 South Road, Changshou chemical industry park, Chongqing Co-patentee after: CHONGQING PHARMACEUTICAL RESEARCH INSTITUTE Co.,Ltd. Patentee after: CHONGQING CARELIFE PHARMACEUTICAL Co.,Ltd. Address before: 401221 No. 2 Yanjiahua South Third Branch Road, Changshou District, Chongqing Co-patentee before: CHONGQING PHARMACEUTICAL RESEARCH INSTITUTE Co.,Ltd. Patentee before: Chongqing Medical Institute Pharmaceutical Co., Ltd. |
|
TR01 | Transfer of patent right |